Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Data from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
  1. Home
  2. Publications
  3. Data from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer

Data from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer

Authors:
  • Sylvia Adams
    Sylvia Adams
  • LKLina Kozhaya
    Lina Kozhaya
  • FMFrank Martiniuk
    Frank Martiniuk
  • TMTze-Chiang Meng
    Tze-Chiang Meng
  • Luis Chiriboga
    Luis Chiriboga
  • LLLeonard Liebes
    Leonard Liebes
  • THTsivia Hochman
    Tsivia Hochman
  • Nicholas Shuman
    Nicholas Shuman
  • Deborah Axelrod
    Deborah Axelrod
  • JSJames Speyer
    James Speyer
  • Yelena Novik
    Yelena Novik
  • Amy Tiersten
    Amy Tiersten

Open Access
Publisher website
Google Scholar
  • 31 March 2023
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.c.6522236.v1
Abstract
No abstract available
Keywords
  • IMIQUIMOD
  • TLR7
  • ABSCOPAL EFFECT
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.